Free Trial

Clorox (NYSE:CLX) Price Target Lowered to $151.00 at JPMorgan Chase & Co.

Clorox logo with Consumer Staples background

Clorox (NYSE:CLX - Free Report) had its price objective reduced by JPMorgan Chase & Co. from $173.00 to $151.00 in a report published on Friday morning,Benzinga reports. They currently have a neutral rating on the stock.

CLX has been the topic of a number of other reports. Royal Bank of Canada reiterated a "sector perform" rating and issued a $150.00 price objective on shares of Clorox in a research report on Thursday, January 30th. Wells Fargo & Company reduced their price objective on shares of Clorox from $161.00 to $155.00 and set an "equal weight" rating on the stock in a research report on Wednesday, April 2nd. Barclays dropped their target price on shares of Clorox from $140.00 to $139.00 and set an "underweight" rating for the company in a research report on Thursday, March 27th. StockNews.com cut shares of Clorox from a "buy" rating to a "hold" rating in a research report on Sunday, January 5th. Finally, Evercore ISI increased their price target on shares of Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. Three investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has given a buy rating to the company. Based on data from MarketBeat, Clorox has an average rating of "Hold" and an average target price of $154.25.

View Our Latest Stock Report on CLX

Clorox Trading Down 0.9 %

Shares of Clorox stock traded down $1.30 on Friday, hitting $138.16. The stock had a trading volume of 358,015 shares, compared to its average volume of 1,295,872. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52. Clorox has a one year low of $127.60 and a one year high of $171.37. The stock's 50-day simple moving average is $147.13 and its two-hundred day simple moving average is $156.93. The stock has a market cap of $17.02 billion, a price-to-earnings ratio of 37.75, a PEG ratio of 2.62 and a beta of 0.61.

Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period in the previous year, the business earned $2.16 EPS. As a group, sell-side analysts predict that Clorox will post 7.15 EPS for the current year.

Clorox Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Wednesday, April 23rd will be given a $1.22 dividend. The ex-dividend date of this dividend is Wednesday, April 23rd. This represents a $4.88 annualized dividend and a yield of 3.53%. Clorox's dividend payout ratio (DPR) is presently 133.33%.

Institutional Investors Weigh In On Clorox

Hedge funds and other institutional investors have recently made changes to their positions in the business. Brooklyn Investment Group boosted its stake in shares of Clorox by 163.8% during the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company's stock worth $25,000 after acquiring an additional 95 shares during the last quarter. Redwood Park Advisors LLC bought a new position in Clorox in the 4th quarter worth $26,000. Continuum Advisory LLC lifted its position in Clorox by 300.0% during the third quarter. Continuum Advisory LLC now owns 184 shares of the company's stock valued at $30,000 after purchasing an additional 138 shares in the last quarter. Millstone Evans Group LLC bought a new stake in Clorox during the fourth quarter valued at about $31,000. Finally, Wood Tarver Financial Group LLC purchased a new stake in Clorox in the fourth quarter worth about $31,000. Hedge funds and other institutional investors own 78.53% of the company's stock.

Clorox Company Profile

(Get Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

See Also

Analyst Recommendations for Clorox (NYSE:CLX)

Should You Invest $1,000 in Clorox Right Now?

Before you consider Clorox, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.

While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Buy the Fear: 3 Down Stocks That Could 10x Your Profits
Congress Bought THESE Stocks as Tariffs Tanked the Market
5 Stocks to BUY Now as Tariff Uncertainty Fades

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines